Artificial Intelligence
Global Clinical Microbiology Instruments and Reagents Market to Reach $6.1 Billion by 2027
New York, July 28, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Clinical Microbiology Instruments and Reagents Industry” – https://www.reportlinker.com/p05957366/?utm_source=GNW
1 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 7.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 7.7% CAGR
The Clinical Microbiology Instruments and Reagents market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$305.3 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.
Select Competitors (Total 59 Featured)
- 3M
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company
- Biomérieux
- Bio-Rad Laboratories, Inc
- Bruker Corporation
- Cepheid Inc
- Danaher Corporation
- Eiken Chemical Co., Ltd.
- Hologic, Inc
- NEOGEN Corporation
- QIAGEN GmbH
- Hoff Man Roche
Diagnostics Division - Shimadzu Corporation
- Thermo Fisher Scientific
Read the full report: https://www.reportlinker.com/p05957366/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
EXHIBIT 1: The World of Clinical Microbiology Gains Sudden
Prominence as Scientists Mobilize United Efforts to Find Ways
to Detect, Treat & Vaccinate People Against the Novel
Coronavirus: Global Scale of Daily Testing Vs Confirmed
Cases Per Million
Clinical Microbiology: An Introduction
Outlook: Evolutionary Battle against Microbes Drives Market Future
Instant Detection of Pathogens : A New Epoch in the Fight for
Survival
Reagents Account for Major Share
Asia-Pacific Drives Future Growth
Recent Market Activity
World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Microbiology Laboratories Switch to Automation to Push Yields
EXHIBIT 2: World Laboratory Automation Market in US$ Billion
for Years 2018, 2020, 2022, 2024 & 2026
Clinical Microbiology Market Benefits from Digitalization and
Robotization Trend
Integration of Clinical Microbiology with Cloud Computing
Artificial Intelligence Holds Positive Implications for
Automation of Clinical Microbiology
Advancements in Molecular Diagnostics Drive Market Growth
Emerging Technologies in Clinical Microbiology Diagnostics Aim
at Faster Diagnosis
Technological Advances Crucial to Sustain Future Market Growth
Rapid Diagnostics Bring in a Transformation
Automated and Rapid Microbiological Tests Revolutionize
Microbiological Testing
Traditional Rapid Microbiological Tests Make Way for New, Probe
Tests
Antibiotic Resistant Bacteria Throws the Spotlight on Microbial
Testing
Research in Stem Cell Technology, and Regenerative Medicine
Expand Growth Opportunities
EXHIBIT 3: Stem Cell Banking Global Market Estimates and
Forecasts in US$ Billion: 2020, 2022 & 2024
Greater Number of Tests for HIV and Sexually Transmitted
Diseases Amplify Growth
EXHIBIT 4: Global HIV Prevalence: Number of People Living with
AIDs (in Thousands) by Region for 2018
EXHIBIT 5: Number of AIDS-Related Deaths (in Thousands) by
Region for 2018
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer
Disease
Home HIV Testing Emerges as a Lucrative Option
Increasing Incidence of Infectious Diseases Drives Growth
EXHIBIT 6: Infectious Diseases Remain Major Cause of Death in
Under Developed Regions: Breakdown of Leading Causes of Death
in Sub-Saharan Africa (in %)
EXHIBIT 7: Infectious Diseases Related Mortality High Among
Children Below 5 Years: Breakdown of Leading Causes of Death
in Children Below 5 Years (in %)
Increasing Prevalence of Respiratory Infections Drive Growth
EXHIBIT 8: Global Number of Deaths Caused Due to Communicable
Diseases (In 000s)
Influenza Boosts Rapid Test Prospects
EXHIBIT 9: Flu Related CDC Estimates from October 2019-April4,
2020
Rise in Prevalence of COPD Augments Demand
EXHIBIT 10: Global Prevalence of COPD by Age Group: Percentage
of Men and Women Affected by the Condition
Rise in Pollution Levels Trigger Increase in Respiratory Diseases
EXHIBIT 11: World Ranking of Most Polluted Countries: 2019
EXHIBIT 12: Percentage Share Breakdown of Global Deaths Linked
to Air Pollution
Increase in Healthcare Spending in Emerging Markets to Propel
Demand
EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
Demographic Shifts & Societal Changes Drive Demand for Test
Volumes
EXHIBIT 14: Elderly Healthcare Expenditure as a % of GDP
EXHIBIT 15: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
EXHIBIT 10: Life Expectancy at Age 60 and 80 Years: (2010-2015
), (2020-2025) & (2045-2050)
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Clinical Microbiology
Instruments and Reagents by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Geographic Region – Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Instruments by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Instruments by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Instruments by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Reagents by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Reagents by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Reagents by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Respiratory
Diseases by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Respiratory Diseases by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Respiratory Diseases by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Bloodstream
Infections by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Bloodstream Infections by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Bloodstream Infections
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Gastrointestinal
Diseases by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Gastrointestinal Diseases
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Gastrointestinal
Diseases by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 19: World Current & Future Analysis for Sexually
Transmitted Diseases by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Sexually Transmitted
Diseases by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Sexually Transmitted
Diseases by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 22: World Current & Future Analysis for Urinary Tract
Infections by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Urinary Tract Infections by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Urinary Tract
Infections by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 25: World Current & Future Analysis for Other Disease
Areas by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Other Disease Areas by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Other Disease Areas by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Hospitals &
Diagnostic Centers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 29: World Historic Review for Hospitals & Diagnostic
Centers by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Hospitals & Diagnostic
Centers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 31: World Current & Future Analysis for Custom Lab
Service Providers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 32: World Historic Review for Custom Lab Service
Providers by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for Custom Lab Service
Providers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 34: World Current & Future Analysis for Academic &
Research Institutes by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 35: World Historic Review for Academic & Research
Institutes by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 36: World 15-Year Perspective for Academic & Research
Institutes by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
III. MARKET ANALYSIS
UNITED STATES
Market Overview
EXHIBIT 16: Healthcare Spending as a % of GDP in the US: 2010-2020
COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests
Table 37: USA Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 38: USA Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 39: USA 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 40: USA Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 41: USA Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 42: USA 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027
Table 43: USA Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: USA Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 45: USA 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027
CANADA
Table 46: Canada Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 47: Canada Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 48: Canada 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 49: Canada Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 50: Canada Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 51: Canada 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027
Table 52: Canada Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Canada Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 54: Canada 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027
JAPAN
Market Overview
Covid-19 Testing Market in Japan
Demographics Drive Market Growth
EXHIBIT 17: Breakdown of Population by Age Group in Japan:
2010, 2020, and 2025
Market Analytics
Table 55: Japan Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 56: Japan Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 57: Japan 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 58: Japan Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 59: Japan Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 60: Japan 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027
Table 61: Japan Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Japan Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 63: Japan 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027
CHINA
Market Overview
Covid-19 Testing Market
Market Analytics
Table 64: China Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 65: China Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 66: China 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 67: China Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 68: China Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 69: China 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027
Table 70: China Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 71: China Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 72: China 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027
EUROPE
Market Overview
COVID-19 Pandemic Propels Demand
Growth in Clinical Diagnostics Automation
Rise in Automated, and Rapid Tests in Clinical Applications
Ageing Demography: An Opportunity Indicator
Market Analytics
Table 73: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Geographic Region –
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 74: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by Geographic Region – France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 75: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Geographic Region – Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Table 76: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 77: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 78: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 79: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 80: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 81: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027
Table 82: Europe Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 83: Europe Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 84: Europe 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027
FRANCE
Table 85: France Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 86: France Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 87: France 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 88: France Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 89: France Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 90: France 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Disease Area – Percentage Breakdown
of Value Sales for Respiratory Diseases, Bloodstream
Infections, Gastrointestinal Diseases, Sexually Transmitted
Diseases, Urinary Tract Infections and Other Disease Areas for
the Years 2012, 2020 & 2027
Table 91: France Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by End-Use – Hospitals &
Diagnostic Centers, Custom Lab Service Providers and Academic &
Research Institutes – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 92: France Historic Review for Clinical Microbiology
Instruments and Reagents by End-Use – Hospitals & Diagnostic
Centers, Custom Lab Service Providers and Academic & Research
Institutes Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 93: France 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by End-Use – Percentage Breakdown of
Value Sales for Hospitals & Diagnostic Centers, Custom Lab
Service Providers and Academic & Research Institutes for the
Years 2012, 2020 & 2027
GERMANY
Table 94: Germany Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Product – Instruments
and Reagents – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Germany Historic Review for Clinical Microbiology
Instruments and Reagents by Product – Instruments and Reagents
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 96: Germany 15-Year Perspective for Clinical Microbiology
Instruments and Reagents by Product – Percentage Breakdown of
Value Sales for Instruments and Reagents for the Years 2012,
2020 & 2027
Table 97: Germany Current & Future Analysis for Clinical
Microbiology Instruments and Reagents by Disease Area –
Respiratory Diseases, Bloodstream Infections, Gastrointestinal
Diseases, Sexually Transmitted Diseases, Urinary Tract
Infections and Other Disease Areas – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 98: Germany Historic Review for Clinical Microbiology
Instruments and Reagents by Disease Area – Respiratory
Diseases, Bloodstream Infections, Gastrointestinal Diseases,
Sexually Transmitted Diseases, Urinary Tract Infections and
Other Disease Areas Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957366/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
Cayman Enterprise City Publishes Socio-Economic Impact Assessment by Economist and Leading Advisor on the Caribbean, Marla Dukharan
The Impact of Cayman Enterprise City’s Socio-Economic Development Project Nears USD $1 Billion
GRAND CAYMAN, Cayman Islands, May 16, 2024 /PRNewswire/ — Cayman Enterprise City (CEC) has released a Socio-Economic Impact Assessment by Marla Dukharan. The report illustrates that CEC is increasing its impact by supporting higher earnings for Caymanians and is driving a shift towards a knowledge-based economy by focusing on high productivity sectors. The release by Dukharan reads, “Caymanian resourcefulness and private sector-led innovation have been the driving force behind the islands’ outstanding socio-economic success. Cayman Enterprise City underpins the next generation of Cayman innovation and dynamism.”
With an economic impact of USD $130 million in 2023, contributing just under USD $1 billion to the local economic activity in 12 years since inception, “CEC is helping the nation to diversify economically, in terms of sectors and jobs, ensuring locals have economic and employment opportunities that match the nation’s progress,” the report reads.
The CEC socio-economic development project is now home to 352 Special Economic Zones Companies (SEZCos), many of which are globally recognised institutions led by top executives and industry experts. “CEC member companies are providing high-value employment with salaries exceeding those typically found outside of the special economic zone,” said Charlie Kirkconnell, Chief Executive Officer at CEC. “The CEC community is fully invested in Cayman and the report illustrates that the CEC socio-economic development project is making a very significant impact on Cayman’s economy and community.”
“As CEC continues to grow, it continues to create significant employment and entrepreneurial opportunities for Caymanians and we encourage anyone that might be interested in finding out how they might get involved, whether as a member of the community and/or as a volunteer in our Enterprise Cayman non-profit organisation (NPO).”
77% of Caymanian-held jobs at CEC member companies, are in sectors with high social returns and increasing global demand. “By putting skills first and prioritizing learning, CEC is enabling new industries to take root,” the release by Dukharan reads.
CEC, through its Enterprise Cayman NPO, is a first-mover in private sector-facilitated education and training in the Caribbean, making it a leading force to boost youth participation in the economy. By offering training in specialised skills, Enterprise Cayman is helping to close the gap in higher education and earnings for Caymanians. “Through Enterprise Cayman we’ve set out to strategically support meaningful employment and entrepreneurial opportunities for Caymanians, by providing internship and mentorship opportunities, by hosting skill-building and career focused training, and by providing invaluable networking and community engagement opportunities,” said Kirkconnell.
In 2023 individuals took advantage of 4,226 opportunities to participate in education, training, and career development events and, since launching entrepreneurial programming in 2021, Enterprise Cayman has worked with 41 new Cayman-born business ventures. “We’re helping to develop a local talent pool that meets the demand of Cayman’s growing digital innovation and technology sectors while, in parallel, offering exciting opportunities for individuals to launch new business ventures within an innovative business environment,” said Kirkconnell.
With CEC’s new campus and state-of-the-art facilities, Signal House, the project “holds the promise of deep, continued economic impact,” the report concludes.
To access CEC’s economic impact assessments and Enterprise Cayman’s annual reports please visit https://www.enterprisecayman.ky/reports. For more information on how to get involved and for upcoming programmes and events visit www.enterprisecayman.ky.
Website: www.caymanenterprisecity.com LinkedIn: @CaymanEnterpriseCityTwitter: @CEC_CaymanInstagram: @CaymanEnterpriseCityFacebook: @CaymanEnterpriseCityYouTube: @ceccayman
About Cayman Enterprise City
Cayman Enterprise City (CEC) is an award-winning development project which consists of three special economic zones (SEZs) focused on attracting knowledge-based and specialised-services businesses to set up a genuine physical presence in the Cayman Islands. The zones included within CEC are Cayman Tech City, Cayman Commodities & Derivatives Centre, and Cayman Maritime & Aviation City. With a dedicated Government Authority, licensing fee concessions and guaranteed fast-track processes, CEC enables international companies to quickly and efficiently establish a Cayman Islands office, which in turn enables them to generate active business income within a tax neutral environment.
About Enterprise Cayman
Enterprise Cayman is a non-profit organisation (NPO) powered by Cayman Enterprise City in partnership with Cayman Islands’ special economic zone companies (SEZCos). The organisation, which applies the Theory of Change (TOC) methodology, provides Caymanians and residents with access to high-quality learning experiences and opportunities to develop and launch new business ventures, to pursue careers within the technology and innovation sectors, and to join a dynamic network of industry professionals. Let’s grow the next generation of Caymanian innovators and entrepreneurs with Enterprise Cayman!
Logo: https://mma.prnewswire.com/media/1317764/2860789/Cayman_Enterprise_City_Logo.jpg
FOR MORE INFORMATION:Contact: Kaitlyn Elphinstone Email: [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/cayman-enterprise-city-publishes-socio-economic-impact-assessment-by-economist-and-leading-advisor-on-the-caribbean-marla-dukharan-302148206.html
Artificial Intelligence
Strava Unveils New Chapter of Accelerated Product Development at Brand’s Flagship Event
The Company introduces increased product velocity, leveraging advancements in Artificial Intelligence, in service of its vision of a world connected through movement
LOS ANGELES, May 16, 2024 /PRNewswire/ — Strava, the leading digital community for active people with more than 125 million athletes, today showcased its latest initiatives and product developments at its annual event, Camp Strava. With the theme of Progress, Together company leaders announced how the platform will empower its global community to make progress in the way they explore, move, and connect on Strava.
“Strava is gaining momentum to realize our vision of a world connected through movement,” said Michael Martin, chief executive officer of Strava. “We are focused on two fundamental shifts to accelerate how we deliver value to 125 million people globally– building for women and leveraging Artificial Intelligence – which will unlock new community-and-partner-powered experiences across the platform.”
A New Era of Product VelocityStrava, with new leaders at the helm, is ushering in its next era of product velocity. The company listened closely to feedback from its global community and announced three of the most requested features coming to the platform by the end of the year.
The first of these updates, AI-enabled Leaderboard Integrity, will harness machine learning to automatically flag irregular, improbable, or impossible activities recorded to the platform. Trained by millions of activities, this feature allows all users on Strava to play fair and have more fun.
Additionally, the company announced a new Family Plan Subscription, the sister of the company’s Student Plan. With Family Plan, it’s easier to make a fitness commitment with your community by sharing an annual subscription with up to three other people – friends, family, or fitness family. Launching in select countries this summer, with plans to roll out globally by the end of the year, Strava’s newest annual subscription option offers the best value for groups (up to four), with a discount off the regular subscription price for each member.
Strava also implemented an updated design system, an initiative that is integral in driving a heightened pace of product innovation at the company. Through this work, Strava announced the launch of one of the company’s most requested features, Dark mode. Dark mode will improve the in-app experience for all users, reducing eye strain and improving accessibility while they record activity or scroll through the feed. Athletes can expect a rollout later this summer with options to keep their mobile settings always dark, always light, or match their device settings.
Company leaders highlighted several other features and updates to current products like Flyover, with its next iteration offering an overlay with activity stats and off-platform sharing capabilities. The overlay is available today for Strava subscribers and an off-platform sharing option will be released later this year.
Build for Her, Build for ManyStudies show that women of all ages participate in sports at a far lower rate than men, and overall, despite wanting to be active, find less time to dedicate to an active lifestyle. As the company continues on its mission to motivate people to live their best active lives, building for women on the platform will ultimately serve everyone in the Strava community. Several new features and initiatives were announced as a part of this strategic focus, which includes:
Night Heatmaps: Night Heatmaps show only activities between sundown and sunrise – so athletes can get an idea of which roads, trails, and paths are well-trafficked after hours. Since Night Heatmaps filter for after-hours routes, it can be a helpful tool for female athletes training before sunrise and after sunset.Quick Edit: For active women, having control over what is shared with the Strava community that cheers them on – like what time a run is logged – is important. Quick Edit makes it easier to make the most common edits – like activity name, and privacy settings so you can hide your start time, your map, or other workout stats.Strive for More®: The company announced a new phase of its Strive for More® initiative, created in 2022 to promote and support women in movement and sport. Today, Strava unveiled an official partnership with media company TOGETHXR to encourage more women to watch – and play – women’s sports. As part of the partnership, Strava will also donate $100,000 to the Alex Morgan Foundation, started by co-founder of TOGETHXR, Alex Morgan, to support their mission to help girls and women find confident paths forward in sports and life.Athlete IntelligenceToday, Strava announced the start of an accelerated product roadmap, outlining how Strava will implement the latest technological enhancements in AI and machine learning, to transform the athlete experience.
One key advancement to the platform includes the company’s latest development, Athlete Intelligence. Strava is introducing its beta AI-powered feature which turns each subscriber’s training data into an easily digestible summary that contextualizes their accomplishments and fitness goals. Unlike other AI-powered training services, Strava connects with thousands of devices, wearables, and fitness apps, so an athlete’s insights can consider their entire fitness story across multiple sports and modalities.
The features shared at Camp Strava will be released on a rolling basis through the end of the year. To view the full list of product releases and further details, visit www.press.strava.com.
For more information on Strava, to create a free account, or to start a free subscription trial visit www.strava.com.
About Strava Strava is the leading digital community for active people with more than 125 million athletes, in more than 190 countries. The platform offers a holistic view of your active lifestyle, no matter where you live, which sport you love and/or what device you use. Everyone belongs on Strava when they are pursuing an active life. Join the community, find motivation and discover new experiences with a Strava subscription.
Visit www.strava.com for more information and connect with Strava on Instagram, Twitter, Facebook, YouTube and LinkedIn.
Media Contact: [email protected]
Photo – https://mma.prnewswire.com/media/2413914/Darkmode_STRAVA.jpgPhoto – https://mma.prnewswire.com/media/2413915/Flyover_STRAVA.jpg Photo – https://mma.prnewswire.com/media/2413913/Athlete_Intelligence_STRAVA__INC.jpg
View original content:https://www.prnewswire.co.uk/news-releases/strava-unveils-new-chapter-of-accelerated-product-development-at-brands-flagship-event-302147068.html
Artificial Intelligence
Japan Data Center Market Investment to Reach $14.48 Billion by 2028 – Watch Out Exclusive Insight on Japan & Hong Kong Data Center Market – Arizton
CHICAGO, May 16, 2024 /PRNewswire/ — Arizton publishes the latest research report on the Japan data center market and Hong Kong data center market.
The Japan Data Center Market to Witness Investments of $14.48 Billion by 2029.
Get Insights on 107 Existing Data Centers and 41 Upcoming Facilities across Japan.
The data center market in Japan is experiencing the emergence of self-built hyperscale data center facilities by major operators such as Google, Microsoft, and Amazon Web Services (AWS). This development is expected to impact the colocation market in Japan. Since these hyperscale operators store workloads in their own data center facilities, it may reduce the source of revenue generation for colocation operators.
Japan is a well-established data center market in the APAC region. The country supports investments with its macroeconomic policies and other incentives for investors. The market is witnessing several investments from local and global data center operators, further expanding its presence. Tokyo and Osaka are Japan’s major destinations for data center development, accounting for over 90% of the existing data center facilities. The government announced the offer of subsidies in Hokkaido and Kyushu for data center development and decentralize data centers from Tokyo and Osaka.
Investment Opportunities
In October 2023, SoftBank and its subsidiary, IDC Frontier, announced the plan to develop a new data center facility in Tomakomai City, Hokkaido. The company invested around $420 million toward the project, for which it received subsidies worth $190 million from the Ministry of Economy, Trade, and Industry. In July 2023, Internet Initiative Japan (IIJ) launched its second data center building at the Shiroi data center campus in Chiba Prefecture, Greater Tokyo. Once fully built, the campus will house four data center buildings. Furthermore, the company is involved in a third expansion initiative in its Matsue City campus (which will likely go live in 2025).In June 2023, Digital Edge, in partnership with Hulic, a real estate developer, announced the start of the construction of a new data center facility, TY07, in Tokyo. The facility is expected to go online by 2025.In April 2024, GDS Services partnered with Gaw Capital to develop a new data center campus in Fuchu City, Tokyo. Both companies will jointly invest toward developing a new data center facility, with the first phase slated to go online by 2026.To Buy this Research Now, Click: https://www.arizton.com/market-reports/japan-data-center-market-investment-analysis
Existing Vs. Upcoming Data Centers
Existing Facilities in the Region (Area and Power Capacity)TokyoOsakaOther CitiesList of Upcoming Facilities in the Region (Area and Power Capacity)TokyoOsakaOther CitiesVendor Analysis
IT Infrastructure Providers: Arista Networks, Atos, Broadcom, Cisco Systems, Dell Technologies, Fujitsu, Hewlett Packard Enterprise (HPE), Hitachi Vantara, Huawei Technologies, IBM, Inspur, Lenovo, NEC, NetApp, and Oracle.
Data Center Construction Contractors & Sub-Contractors: Arup, AECOM, Daiwa House Industry, Fuji Furukawa Engineering & Construction, Hibiya Engineering, ISG, Kajima Corporation, Keihanshin Building, Linesight, MARCAI DESIGN, Meiho Facility Works, Nikken Sekkei, NTT FACILITIES, Obayashi Corporation, SHINRYO Corporation, TAISEI Corporation.
Support Infrastructure Providers: 3M, ABB, Alfa Laval, Caterpillar, Cummins, Delta Electronics, Eaton, Fuji Electric, HITEC Power Protection, Johnson Controls, Kawasaki Heavy Industries, KOHLSER-SDMO, Legrand, Mitsubishi Electric, Rittal, Rolls-Royce, Schneider Electric, STULZ, Siemens, Vertiv.
Data Center Investors: AirTrunk, Alibaba Cloud, Amazon Web Services, AT TOKYO, Colt Data Centre Services, Digital Edge, Equinix, Fujitsu, Goodman, Google, IDC Frontier, Internet Initiative Japan (IIJ), MC Digital Realty, Microsoft, NTT Communications, SCSK Corporation (NETXDC), Telehouse, Tencent Cloud, TIS INTEC Group.
New Entrants: Ada Infrastructure, Edge Centres, CyrusOne, ESR, GDS Services, Keppel Data Centres, NEXTDC, Princeton Digital Group (PDG), SC Zeus Data Center, STACK Infrastructure, ST Telemedia Global Data Centres, Vantage Data Centers, Yondr.
The Hong Kong Data Center Market will Witness Investments of $4.80 Billion by 2029.
Get Insights on 54 Existing Data Centers and 12 Upcoming Facilities across Hong Kong.
The Hong Kong data center market is booming, driven by the increasing demand for digital services. The data center investments in Hong Kong over the next two to three years are expected to remain high due to the surge in demand and the significant boost due to the advancements in AI technologies. Investors are actively investing in this market.
Hong Kong is a mature and thriving market for data center development in the APAC region. Investors find it an attractive market owing to the high internet and social media usage levels, a robust business ecosystem, and excellent connectivity through both inland and submarine cables. Additionally, the deployment of 5G technology further enhances its appeal.
Hong Kong stands out globally for the incredibly high rates of cell phone and home broadband service usage. With around 300 licensed internet service providers, there is robust competition, providing data center operators with a wide range of choices.
Hong Kong is considered an attractive destination for businesses due to various reasons. Its proximity to mainland China and its import-export relations with major markets, such as China and the US, make it easier for businesses to operate. Additionally, the market has experienced significant growth in Foreign Direct Investment (FDI), ranking after countries like the UK, the US, and China.
Investment Opportunities
In December 2023, the company completed the core and shell construction of phase-1 of the MEGA IDC data center campus. The facility has already signed lease agreements with cloud service providers and international banks for its available space. The company plans to expand the campus through phase-2 during the forecast period.In March 2023, the company launched its seventh data center facility, MEGA Gateway, in Tsuen Wan. The facility is part of its connected MEGA campus.Goodman is among the major investors in the Hong Kong market, and it is continuously expanding its data center presence. In March 2024, the company announced the construction of the new Texaco data center facility in Tsuen Wan. The facility is a brownfield construction that involved the conversion of an industrial building into a data center facility. The facility is likely to go online by 2026.Over 60% Of Future Demand to Come from Cloud Service Providers
The Hong Kong data center market has the presence of on-premises data centers operated by educational institutions, the government, and financial services such as HSBC Bank. A significant decline in on-premises data centers will occur in the next three to five years owing to the increase in digitalizing initiatives across sectors and the strong growth in demand for colocation and cloud services. In addition, most existing service providers offer managed solutions to enterprise customers, which will likely grow in the market from 2024-2029.
The market has the presence of all global cloud operators, such as Amazon Web Services (AWS), Google, Microsoft, Alibaba Cloud, Huawei Cloud, and Tencent Cloud. This will propel the demand for wholesale colocation services through these service providers’ continuous expansion initiatives. The cloud segments will likely dominate capacity take-up over the next five years. In addition, the market will witness the entry of multiple global organizations to service customers through a local presence.
To Buy this Research Now, Click: https://www.arizton.com/market-reports/hong-kong-data-center-market-size-analysis
Existing VS. Upcoming Data Centers
Existing Facilities in the Region (Area and Power Capacity)Tseung Kwan OKwai ChungTsuen WanFanlingFo TanChai WanTai PoOther LocationList of Upcoming Facilities in the Region (Area and Power Capacity)Tseung Kwan OKwai ChungTsuen WanFanlingFo TanChai WanTai PoOther LocationVendor Analysis
IT Infrastructure Providers: Arista Network, Atos, Cisco Systems, Dell Technologies, Fujitsu, Hewlett Packard Enterprise (HPE), Huawei Technologies, IBM, Inspur, Lenovo, NetApp.
Data Center Construction Contractors & Sub-Contractors: Arup, AtkinsRéalis, Aurecon, BYME Engineering, Chung Hing Engineers Group, Cundall, DSCO Group, Gammon Construction, ISG, Studio One Design.
Support Infrastructure Providers: ABB, Airedale, Caterpillar, Cummins, Delta Electronics, Eaton, Fuji Electric, KOHLER, Legrand, Mitsubishi Electric, Piller Power Systems, Rittal, Schneider Electric, Siemens, STULZ, Sumber, Vertiv.
Data Center Investors: AirTrunk, BDx, CITIC Telcom International, China Mobile International (CMI), China Unicom, Digital Realty, Equinix, ESR, GDS Services, Global Switch, Goodman, iTech Towers Data Centre Services, NTT DATA, SUNeVision Holdings (iAdvantage), Telehouse, Towngas Telecom (TGT), Vantage Data Centers.
New Entrants: Angelo Gordon and Mapletree Investments
Japan & Hong Kong Data Center Market Segmentation
IT Infrastructure
Servers
Storage Systems
Network Infrastructure
Electrical Infrastructure
UPS Systems
Generators
Transfer Switches & Switchgears
PDUs
Other Electrical Infrastructure
Mechanical Infrastructure
Cooling Systems
Rack Cabinets
Other Mechanical Infrastructure
Cooling Systems
CRAC & CRAH Units
Chiller Units
Cooling Towers, Condensers & Dry Coolers
Economizers & Evaporative Coolers
Other Cooling Units
General Construction
Core & Shell Development
Installation & Commissioning Services
Engineering & Building Design
Fire Detection & Suppression Systems
Physical Security
DCIM
Tier Standard
Tier I & Tier II
Tier III
Tier IV
Check Out Some of the Top Selling Research Reports:
Malaysia Data Center Market – Investment Analysis & Growth Opportunities 2024-2029https://www.arizton.com/market-reports/malaysia-data-center-market-size-analysis
Singapore Data Center Market – Investment Analysis & Growth Opportunities 2024-2029https://www.arizton.com/market-reports/singapore-data-center-market-size-analysis
Southeast Asia Data Center Construction Market – Industry Outlook & Forecast 2024-2029https://www.arizton.com/market-reports/southeast-asia-data-center-construction-market
Why Arizton?
100% Customer Satisfaction
24×7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton’s report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Contact Us Call: +1-312-235-2040 +1 302 469 0707 Mail: [email protected] Contact Us: https://www.arizton.com/contact-us Blog: https://www.arizton.com/blog Website: https://www.arizton.com/
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/japan-data-center-market-investment-to-reach-14-48-billion-by-2028–watch-out-exclusive-insight-on-japan–hong-kong-data-center-market—arizton-302147784.html
-
Artificial Intelligence7 days agoSanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
-
Artificial Intelligence7 days agoIdentity Threat Detection and Response (ITDR) Market worth $35.6 billion by 2029- Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence7 days agoNorthern Data Group’s Peak Mining announces new partnership for 28MW of mining, powered by 100% renewable energy
-
Artificial Intelligence7 days ago
atNorth Shortlisted for Datacloud Global Awards, The Energy Awards and The Women in Green Business Awards
-
Artificial Intelligence6 days agoWIO Taps Gracenote to Revolutionize Television Broadcast Reporting
-
Artificial Intelligence7 days ago
Linnovate Partners Announces Close of USD 40 Million Funding Commitment Led by SeaTown
-
Artificial Intelligence7 days ago
CoreWeave Invests £1 Billion in UK; Opens New European Headquarters and Data Centres in London to Bring Cloud Infrastructure to Power the AI Revolution
-
Artificial Intelligence7 days agoProofID wins Judges’ Award for Global Ambition at the 2024 Northern Tech Awards
